TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
Crossref DOI link: https://doi.org/10.1098/rsob.200099
Published Online: 2020-09-02
Published Print: 2020-09
Update policy: https://doi.org/10.1098/crossmark-policy
Totzke, Juliane
Scarneo, Scott A. https://orcid.org/0000-0002-8128-8426
Yang, Kelly W.
Haystead, Timothy A. J.
Version of Record valid from 2020-09-01
Text and Data Mining valid from 2020-09-01
Publication History
Received: 2020-04-16
Accepted: 2020-08-11
Published: 2020-09-02
